2/19/2025 2:57:21 PM Increased risks for Australian life sciences businesses under the EU’s modernised product liability regime By Rebecca Currey Tom Johnston A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...
2/11/2025 8:39:19 AM Strengthening Pharma IP: China’s Boost to Data and Market Exclusivity By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...